» Articles » PMID: 19495809

Saliva Substitutes for the Treatment of Radiation-induced Xerostomia--a Review

Overview
Specialties Critical Care
Oncology
Date 2009 Jun 5
PMID 19495809
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Goal: The aim of this review is to summarize the in vitro and in vivo evidence on the performance of contemporary saliva substitutes in the treatment of xerostomia and hyposalivation caused by radiation therapy for head and neck malignancies.

Methods: A literature search was conducted during July to September 2008 in PubMed, using the query terms "saliva substitute", "saliva substitute and xerostomia", "artificial saliva", and "artificial saliva and xerostomia"; for clinical studies, only studies in patients suffering from radiation-induced xerostomia have been included in the review.

Results And Conclusion: Fifty-two studies met the inclusion criteria and were allotted either to the in vitro topics "viscosity", "lubrication", "wetting properties", "antimicrobial effects", and "enamel and dentin de- and remineralization", or to the in vivo topics "clinical acceptance" or "influence on plaque formation and oral mucosa and microflora". The findings suggest that there are significant differences in the performance of various saliva substitutes concerning the review parameters, yet indicate that further in vitro and in vivo studies on the properties of saliva substitutes are necessary.

Citing Articles

Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292).

Reingold R, Parisi R, Harada G, Moy A, Dranitsaris G, Francis J JTO Clin Res Rep. 2025; 6(3):100792.

PMID: 39990138 PMC: 11847245. DOI: 10.1016/j.jtocrr.2025.100792.


The Oral Microbial Ecosystem in Age-Related Xerostomia: A Critical Review.

Pei X, Zhou L, Tsang M, Tai W, Wong S Int J Mol Sci. 2024; 25(23.

PMID: 39684528 PMC: 11640827. DOI: 10.3390/ijms252312815.


Clinical outcomes of NBF gel application in managing mucositis associated with xerostomia.

Szabo G, Nemeth Z, Kivovics M Maxillofac Plast Reconstr Surg. 2024; 46(1):34.

PMID: 39342518 PMC: 11439858. DOI: 10.1186/s40902-024-00445-6.


Investigation of Hydrocolloid Plant Polysaccharides as Potential Candidates to Mimic the Functions of MUC5B in Saliva.

Winter C, Tetyczka C, Pham D, Kolb D, Leitinger G, Schonfelder S Pharmaceutics. 2024; 16(5).

PMID: 38794344 PMC: 11124828. DOI: 10.3390/pharmaceutics16050682.


The in vitro assessment of rheological properties and dentin remineralization of saliva substitutes containing propolis and aloe vera extracts.

Srisomboon S, Intharah T, Jarujareet U, Toneluck A, Panpisut P PLoS One. 2024; 19(5):e0304156.

PMID: 38776324 PMC: 11111055. DOI: 10.1371/journal.pone.0304156.


References
1.
Andersson G, Johansson G, Attstrom R, Edwardsson S, Glantz P, Larsson K . Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology. 1995; 12(1):12-7. DOI: 10.1111/j.1741-2358.1995.tb00124.x. View

2.
van der Reijden W, Buijs M, Damen J, Veerman E, Ten Cate J, Nieuw Amerongen A . Influence of polymers for use in saliva substitutes on de- and remineralization of enamel in vitro. Caries Res. 1997; 31(3):216-23. DOI: 10.1159/000262403. View

3.
Mellema J, Holterman H, Waterman H, Blom C, Gravenmade E . Rheological aspects of mucin-containing solutions and saliva substitutes. Biorheology. 1992; 29(2-3):231-49. DOI: 10.3233/bir-1992-292-304. View

4.
Shahdad S, Taylor C, Barclay S, Steen I, Preshaw P . A double-blind, crossover study of Biotène Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia. Eur J Cancer Care (Engl). 2005; 14(4):319-26. DOI: 10.1111/j.1365-2354.2005.00587.x. View

5.
Hatton M, LeVine M, Margarone J, Aguirre A . Lubrication and viscosity features of human saliva and commercially available saliva substitutes. J Oral Maxillofac Surg. 1987; 45(6):496-9. DOI: 10.1016/s0278-2391(87)80009-5. View